Suppr超能文献

抗细胞间黏附分子-1单克隆抗体在心肌缺血再灌注中的冠状动脉内皮保护及心脏保护作用

Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion.

作者信息

Ma X L, Lefer D J, Lefer A M, Rothlein R

机构信息

Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.

出版信息

Circulation. 1992 Sep;86(3):937-46. doi: 10.1161/01.cir.86.3.937.

Abstract

BACKGROUND

Intercellular adhesion molecule-1 (ICAM-1) is a major ligand on endothelial cells for adherence of activated polymorphonuclear leukocytes (PMNs). The major purpose of this study was to study the effects of RR1/1, a monoclonal antibody against ICAM-1 (i.e., MAb RR1/1), on myocardial injury and endothelial dysfunction associated with myocardial ischemia and reperfusion.

METHODS AND RESULTS

Either MAb RR1/1 (2 mg/kg, n = 7), an antibody that was found to bind selectively to endothelial cells in the cat, or MAb R3.1 (2 mg/kg, n = 7), a nonbinding control antibody, was given as an intravenous bolus 10 minutes before reperfusion. Two hundred eighty minutes later, hearts were excised. The left ventricle area-at-risk (AAR) was similar in MAb RR1/1 (29 +/- 2%) and MAb R3.1 (30 +/- 3%) groups. In MAb R3.1-treated cats, 90 minutes of myocardial ischemia plus 4.5 hours of reperfusion induced a significant myocardial injury (necrotic tissue/AAR, 28 +/- 2%), high myeloperoxidase activity (0.65 +/- 0.16 units/100 mg ischemic tissue), and a marked decrease in endothelium-dependent vasorelaxation in isolated left anterior descending coronary arteries (vasorelaxation to acetylcholine, 29 +/- 3%) with no change in endothelium-independent vasorelaxation (relaxation to NaNO2, 91 +/- 3%). However, cats treated with MAb RR1/1 developed significantly less myocardial necrosis (10 +/- 2% of the AAR, p less than 0.01), lower myeloperoxidase activity in ischemic myocardial tissue (0.2 +/- 0.03 units/100 mg ischemic tissue, p less than 0.01), and enhanced vasorelaxant responses to endothelial-dependent relaxation to acetylcholine (53 +/- 5%) compared with ischemic/reperfused cats treated with Mab R3.1. Furthermore, addition of MAb RR1/1 in vitro significantly inhibited unstimulated PMN adherence to ischemic-reperfused coronary artery endothelium.

CONCLUSIONS

These results suggest that ICAM-1-dependent PMN adherence plays an important role in reperfusion injury, and that PMN adherence and infiltration contribute significantly to coronary endothelial dysfunction.

摘要

背景

细胞间黏附分子 -1(ICAM -1)是内皮细胞上的主要配体,用于活化的多形核白细胞(PMN)的黏附。本研究的主要目的是研究抗ICAM -1单克隆抗体RR1/1(即MAb RR1/1)对与心肌缺血和再灌注相关的心肌损伤和内皮功能障碍的影响。

方法与结果

在再灌注前10分钟静脉推注MAb RR1/1(2mg/kg,n = 7),一种被发现能选择性结合猫内皮细胞的抗体,或MAb R3.1(2mg/kg,n = 7),一种非结合对照抗体。280分钟后,取出心脏。MAb RR1/1组(29±2%)和MAb R3.1组(30±3%)的左心室危险面积(AAR)相似。在MAb R3.1治疗的猫中,90分钟的心肌缺血加4.5小时的再灌注导致显著的心肌损伤(坏死组织/AAR,28±2%)、高髓过氧化物酶活性(0.65±0.16单位/100mg缺血组织),以及离体左前降支冠状动脉内皮依赖性血管舒张显著降低(对乙酰胆碱的血管舒张,29±3%),而内皮非依赖性血管舒张无变化(对亚硝酸钠的舒张,91±3%)。然而,与用MAb R3.1治疗的缺血/再灌注猫相比,用MAb RR1/1治疗的猫心肌坏死明显减少(AAR的10±2%,p<0.01),缺血心肌组织中的髓过氧化物酶活性较低(0.2±0.03单位/100mg缺血组织,p<0.01),并且对内皮依赖性舒张剂乙酰胆碱的血管舒张反应增强(53±5%)。此外,在体外添加MAb RR1/1可显著抑制未刺激的PMN对缺血 - 再灌注冠状动脉内皮的黏附。

结论

这些结果表明,依赖ICAM -1的PMN黏附在再灌注损伤中起重要作用,并且PMN黏附和浸润对冠状动脉内皮功能障碍有显著贡献。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验